Day: March 20, 2026

GigaCloud Technology Inc Announces Marketplace Initiative with Otto Group to Expand Assortment in Europe

Written by Customer Service on March 20, 2026. Posted in Public Companies.

EL MONTE, Calif., March 20, 2026 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced a marketplace initiative with Otto Group, one of Europe’s largest ecommerce and retail enterprises. As part of this initiative, GigaCloud will facilitate the introduction of select sellers, including leading furniture brands and suppliers, to Otto’s established European selling platform. The initiative is intended to broaden marketplace assortment while leveraging GigaCloud’s global supplier network and technology capabilities. “This collaboration aligns with our channel-agnostic strategy and reinforces our role as a marketplace solutions provider, connecting global supply with established selling...

Canterra Minerals Engages Atrium Research to Enhance Investor Visibility and Institutional Reach

Written by Customer Service on March 20, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV:CTM) (OTCQB: CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to announce it has engaged Atrium Research Corporation (“Atrium”), a prominent firm specializing in company-sponsored research, to support broader market awareness of Canterra’s exploration portfolio and ongoing 2026 drill programs. Atrium will be responsible for publishing various research reports on Canterra. These reports will be based on publicly available information, industry data, and direct discussions with the Company’s management and are expected to provide investors with detailed, third-party analysis of Canterra’s assets and exploration strategy. Additionally, Atrium will conduct and host two recorded interviews with Canterra’s...

Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer

Written by Customer Service on March 20, 2026. Posted in Public Companies.

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will host a key opinion leader (KOL) webinar to discuss the emergent treatment landscape in first-line RAS-mutated metastatic colorectal cancer (mCRC). The webinar will take place on Wednesday, March 25th, 2026, at 4:30 p.m. ET. The webinar will feature KOLs Scott Kopetz, M.D., Ph.D., FACP and Heinz-Josef Lenz, M.D., who will join Mani Mohindru, PhD, interim Chief Executive Officer, to discuss onvansertib’s existing clinical data and its potential as a novel therapeutic approach in the management of mCRC. About the KOLs Scott Kopetz, M.D., Ph.D., FACP, is a Professor in the Department of Gastrointestinal...

Aurora Mobile’s EngageLab Redefines Marketing Agility at MarketingPulse: Bridging AI Trends with Unified Execution

Written by Customer Service on March 20, 2026. Posted in Public Companies.

SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced that its AI-first customer engagement platform, EngageLab, successfully concluded its high-profile participation at Hong Kong MarketingPulse & eTailingPulse 2026, organized by HKTDC. Throughout the event at the HKCEC, EngageLab’s Booth became a premier destination for marketers seeking to “Redefine Customer Relationships for the AI Era.” Turning AI Trends into Marketing Reality MarketingPulse 2026 was abuzz with discussions on Agentic AI, reflecting a critical shift in the industry: marketers are no longer looking for simple automation, but for intelligent “agents” capable of autonomous reasoning...

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Written by Customer Service on March 20, 2026. Posted in Public Companies.

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAEZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that two articles have been published back-to-back in the same issue of The Lancet Haematology. The articles detail data from the two randomized Phase 2 studies, CHAPTER-1 and RAPIDe-1, evaluating the efficacy and safety of deucrictibant, a potent, orally bioavailable small-molecule bradykinin B2 receptor antagonist,...

BitFuFu Announces Unaudited 2025 Full-Year Financial Results

Written by Customer Service on March 20, 2026. Posted in Earnings Releases And Operating Results.

SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial HighlightsTotal revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations. For the Year Ended December 31, 2025 2024Business Segment ($ in millions) Revenue % ofRevenue Revenue % ofRevenueCloud Mining Solutions $ 350.6 73.7 % $ 271.0 58.5 % Self-Mining Operations 63.1 13.3 % 157.5 34.0 % Mining...

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

Written by Customer Service on March 20, 2026. Posted in Dividend Reports And Estimates.

SAN JUAN CAPISTRANO, Calif., March 20, 2026 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before April 30, 2026, to shareholders of record as of March 31, 2026. Ensign has been a dividend-paying company since 2002. About Ensign™ The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services...

OSB GROUP PLC – Block Application for Admission to Trading

Written by Customer Service on March 20, 2026. Posted in Public Companies.

LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the Company) Block Application for Admission to Trading A block application has been made to the London Stock Exchange for a total of 500,000 Ordinary Shares of £0.01 each (the Shares) to be admitted to trading. The Shares shall rank equally with the existing issued Shares of the Company. Admission is expected on or around 24 March 2026. Shares will be allotted from time to time following the exercise of options pursuant to the Company’s Deferred Share Bonus Plan. Enquiries:OSB GROUP PLCJess PetrieGroup Head of Corporate Governance t: 01634 835 796 BrunswickRobin Wrench / Simone Selzer t: 020 7404 5959 Notes to Editors About OSB GROUP PLCs OSB began trading as a bank on 1 February 2011 and was admitted to the main market of the London Stock Exchange in June...

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

Written by Customer Service on March 20, 2026. Posted in Mergers And Acquisitions.

Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million Breathe Right is an iconic and category‑leading brand with strong margins and cash flow generation Acquisition reinforces Prestige’s long-term organic growth algorithm Transaction expected to close in Prestige’s first half fiscal 2027TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million. Breathe Right®, created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category and...

Digitalage Introduces Stateful Media Infrastructure: The Architecture That Converts Every Live Stream Into a Permanent, Searchable, Monetizable Asset at Creation

Written by Customer Service on March 20, 2026. Posted in Public Companies.

Hop-on, Inc. (OTCID: HPNN) Defines the Category, Documents the Proof, and Positions as the Only Production Platform Operating Within It In simple terms: every live stream on Digitalage becomes a permanent, searchable, monetizable asset the moment it starts. That is Stateful Media Infrastructure. A technical and economic reclassification of what media is, how it works, and who captures value from it. The company that controls this infrastructure layer controls the economic foundation beneath the entire creator economy. Digitalage has built it, deployed it, and put it on the public record. TEMECULA, Calif., March 20, 2026 (GLOBE NEWSWIRE) — Hop-on, Inc. (OTCID: HPNN), through its subsidiary Digitalage, today introduced Stateful Media Infrastructure: a new infrastructure category and the framework beneath three sequential public milestones...

Day: March 20, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals